Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...

AstraZeneca chief executive Pascal Soriot said the company took the detention of its China president “very seriously”, as the drugmaker raised its guidance for a second straight quarter on the back of ...

Pharmaceuticals giant Astrazeneca has reported double-digit sales growth on higher demand and said it remains committed to ...

AstraZeneca boss Pascal Soriot (pictured)) threw his weight behind its Chinese business despite the recent arrest of its boss ...

London-listed drugmaker AstraZeneca said its plan to invest 450 million pounds ($576.7 million) in Britain for vaccine ...

AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns ...

In the year to date we have announced the results for multiple positive high-value trials and are working to bring these ... research was well recognised this quarter with data for AstraZeneca ...

Reports Q3 revenue $13.6B, consensus $13.09B. Pascal Soriot, CEO, AstraZeneca (AZN), commenting on the results said: “Our company has ...

AstraZeneca PLC (NASDAQ:AZN) announced a $3.5 billion investment in the US for manufacturing and R&D, highlighting its ...

The AstraZeneca share price has fallen almost 25% since late August. Is there value on offer for investors after this huge ...

“In the year to date we have announced the results for multiple positive high-value trials and are working to bring these new ...